Original Source(s)
Related Content
FDA Expands Guselkumab Label in PsA
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
-
2 min
Transdermal NSAID Matches Oral Celecoxib After Knee Replacement
Randomized trial finds a topical anti-inflammatory patch provided similar pain relief, function, and safety as oral therapy during the first 6 weeks after surgery.
by Doug Brunk
July 2, 2026
-
4 min
Medical Oddities: Ancient Practice Calms Modern BP
Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.
by Teraya Smith
May 13, 2026
-
5 min
